In this interview Xiaojue Hu, MD and I continue the conversation about psychedelics in psychiatry. Xiaojue Hu, MD, is a psychiatrist, clinical assistant professor of psychiatry at NYU, and a psychedelic researcher as part of the NYU group investigating the use of psilocybin to treat depression. She is also a part of our clinical team here. In this video we discuss the very important and often overlooked aspects of psychedelic integration.
Show Notes:
[01:18] How psychedelics fit into conventional psychiatry
[02:55] Does it matter if the patient is in a clinical setting or in nature while taking psychedelics?
[04:30] How does psychedelic integration play a role in therapy
[07:30] Is this pharmacological and spiritual?
[09:45] Psychedelics integration presents an opportunity to make new choices
